The global penicillin market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of bacterial infections and antibiotic resistance. The increasing prevalence of bacterial infections and antibiotic resistance are driving the demand for penicillin drugs globally. The global penicillin market by type includes aminopenicillins, antipseudomonal penicillins, betlactamase inhibitors, natural penicillins, and pencillinase resistant pencillins. Aminopenicillins accounted for the largest share in 2018 due to their broad spectrum activity against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae which are major causes of hospital acquired infections (HAIs). Antipseudomonal Pencillin has been used extensively in treatment of HAIs caused by Gram-negative bacteria such as Pseudomonas aeruginosa which have become resistant to other antibiotics such as cephalosporins or carbapenems. Natural Pencillin has been used extensively in treatment HAIs caused by Gram-positive bacteria such as Staphylococcus aureus which have become resistant to other antibiotics such as cephalosporins or carbapenems. Penicillin is a type of antibiotic that is used to treat bacterial infections. Penicillin was discovered in 1928 by Alexander Fleming and it has been used ever since. The market for penicillin is growing because there are more people getting sick with bacterial infections, the population is increasing, and there are new strains of bacteria that penicillin can't kill.
Industry Growth Insights published a new data on “Penicillin Market”. The research report is titled “Penicillin Market research by Types (Aminopenicillins, Antipseudomonal Penicillins, Beta-lactamase Inhibitors, Natural Penicillins, Penicillinase Resistant Penicillins), By Applications (Hospitals, Clinics, Others), By Players/Companies GSK, Pfizer, Johnson & Johnson, Bayer HealthCare, Abbot Laboratories, Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Toyama Chemical, Merck & Co.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Penicillin Market Research Report
By Type
Aminopenicillins, Antipseudomonal Penicillins, Beta-lactamase Inhibitors, Natural Penicillins, Penicillinase Resistant Penicillins
By Application
Hospitals, Clinics, Others
By Companies
GSK, Pfizer, Johnson & Johnson, Bayer HealthCare, Abbot Laboratories, Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Toyama Chemical, Merck & Co.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Penicillin Market Report Segments:
The global Penicillin market is segmented on the basis of:
Types
Aminopenicillins, Antipseudomonal Penicillins, Beta-lactamase Inhibitors, Natural Penicillins, Penicillinase Resistant Penicillins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Pfizer
- Johnson & Johnson
- Bayer HealthCare
- Abbot Laboratories
- Roche Pharmaceuticals
- Sanofi Aventis
- Takeda Pharmaceutical Company
- Toyama Chemical
- Merck & Co.
Highlights of The Penicillin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aminopenicillins
- Antipseudomonal Penicillins
- Beta-lactamase Inhibitors
- Natural Penicillins
- Penicillinase Resistant Penicillins
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Penicillin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Penicillin is a type of antibiotic. Antibiotics help fight infection by bacteria.
Some of the major players in the penicillin market are GSK, Pfizer, Johnson & Johnson, Bayer HealthCare, Abbot Laboratories, Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Toyama Chemical, Merck & Co..
The penicillin market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Penicillin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Penicillin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Penicillin Market - Supply Chain
4.5. Global Penicillin Market Forecast
4.5.1. Penicillin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Penicillin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Penicillin Market Absolute $ Opportunity
5. Global Penicillin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Penicillin Market Size and Volume Forecast by Type
5.3.1. Aminopenicillins
5.3.2. Antipseudomonal Penicillins
5.3.3. Beta-lactamase Inhibitors
5.3.4. Natural Penicillins
5.3.5. Penicillinase Resistant Penicillins
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Penicillin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Penicillin Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Penicillin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Penicillin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Penicillin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Penicillin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Penicillin Demand Share Forecast, 2019-2026
9. North America Penicillin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Penicillin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Penicillin Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Penicillin Market Size and Volume Forecast by Type
9.7.1. Aminopenicillins
9.7.2. Antipseudomonal Penicillins
9.7.3. Beta-lactamase Inhibitors
9.7.4. Natural Penicillins
9.7.5. Penicillinase Resistant Penicillins
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Penicillin Demand Share Forecast, 2019-2026
10. Latin America Penicillin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Penicillin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Penicillin Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Penicillin Market Size and Volume Forecast by Type
10.7.1. Aminopenicillins
10.7.2. Antipseudomonal Penicillins
10.7.3. Beta-lactamase Inhibitors
10.7.4. Natural Penicillins
10.7.5. Penicillinase Resistant Penicillins
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Penicillin Demand Share Forecast, 2019-2026
11. Europe Penicillin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Penicillin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Penicillin Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Penicillin Market Size and Volume Forecast by Type
11.7.1. Aminopenicillins
11.7.2. Antipseudomonal Penicillins
11.7.3. Beta-lactamase Inhibitors
11.7.4. Natural Penicillins
11.7.5. Penicillinase Resistant Penicillins
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Penicillin Demand Share, 2019-2026
12. Asia Pacific Penicillin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Penicillin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Penicillin Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Penicillin Market Size and Volume Forecast by Type
12.7.1. Aminopenicillins
12.7.2. Antipseudomonal Penicillins
12.7.3. Beta-lactamase Inhibitors
12.7.4. Natural Penicillins
12.7.5. Penicillinase Resistant Penicillins
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Penicillin Demand Share, 2019-2026
13. Middle East & Africa Penicillin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Penicillin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Penicillin Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Penicillin Market Size and Volume Forecast by Type
13.7.1. Aminopenicillins
13.7.2. Antipseudomonal Penicillins
13.7.3. Beta-lactamase Inhibitors
13.7.4. Natural Penicillins
13.7.5. Penicillinase Resistant Penicillins
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Penicillin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Penicillin Market: Market Share Analysis
14.2. Penicillin Distributors and Customers
14.3. Penicillin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer HealthCare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbot Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi Aventis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Takeda Pharmaceutical Company
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Toyama Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merck & Co.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook